Val-Ala-PAB-SN38 TFA is a drug-linker conjugate for ADCs, composed of the ADC linker Val-Ala-PAB and SN38, which is the active metabolite of the topoisomerase I (Topoisomerase I) inhibitor irinotecan.
Target:
Drug-Linker Conjugates for ADC
* VAT and and shipping costs not included. Errors and price changes excepted
